Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1977 5
1978 1
1979 2
1981 1
1983 2
2010 1
2011 1
2012 1
2013 2
2014 1
2015 4
2016 3
2017 2
2018 5
2019 8
2020 2
2021 5
2022 4
2023 3
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

52 results

Results by year

Filters applied: . Clear all
Page 1
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study.
Cohen EEW, Soulières D, Le Tourneau C, Dinis J, Licitra L, Ahn MJ, Soria A, Machiels JP, Mach N, Mehra R, Burtness B, Zhang P, Cheng J, Swaby RF, Harrington KJ; KEYNOTE-040 investigators. Cohen EEW, et al. Lancet. 2019 Jan 12;393(10167):156-167. doi: 10.1016/S0140-6736(18)31999-8. Epub 2018 Nov 30. Lancet. 2019. PMID: 30509740 Clinical Trial.
Avelumab-based neoadjuvant therapy in patients with muscle-invasive bladder cancer (AURA Oncodistinct-004): a phase 2 multicenter clinical trial.
Blanc J, Carnot A, Barthélémy P, Casert V, Sautois B, Van den Brande J, Vanhaudenarde V, Staudacher L, Seront E, Debien V, Ameye L, Kotecki N, Rothé F, Rorive S, Fantoni JC, Tricard T, Roumeguère T, Awada A, Martinez Chanza N. Blanc J, et al. Among authors: kotecki n. J Immunother Cancer. 2025 May 24;13(5):e012045. doi: 10.1136/jitc-2025-012045. J Immunother Cancer. 2025. PMID: 40413024 Free PMC article. Clinical Trial.
[Factitious diseases in oncology].
Reich M, Clermont A, Amela É, Kotecki N. Reich M, et al. Among authors: kotecki n. Bull Cancer. 2015 Dec;102(12):1036-45. doi: 10.1016/j.bulcan.2015.09.006. Epub 2015 Nov 18. Bull Cancer. 2015. PMID: 26597474 Review. French.
52 results